A
Amy Berrington de Gonzalez
Researcher at National Institutes of Health
Publications - 134
Citations - 22173
Amy Berrington de Gonzalez is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 41, co-authored 99 publications receiving 18899 citations. Previous affiliations of Amy Berrington de Gonzalez include University of Oxford.
Papers
More filters
Journal ArticleDOI
Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study
Mark S. Pearce,J Salotti,Mark P. Little,Kieran McHugh,Choonsik Lee,Kwang Pyo Kim,Nicola Howe,Cécile M. Ronckers,Preetha Rajaraman,Alan W. Craft,Louise Parker,Amy Berrington de Gonzalez +11 more
TL;DR: Use of CT scans in children to deliver cumulative doses of about 50 mGy might almost triple the risk of leukaemia and doses ofabout 60 m Gy might triple therisk of brain cancer.
Journal ArticleDOI
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer.
Rebecca Smith-Bindman,Jafi A. Lipson,Ralph Marcus,Kwang Pyo Kim,Mahadevappa Mahesh,Robert G. Gould,Amy Berrington de Gonzalez,Diana L. Miglioretti +7 more
TL;DR: Radiation doses from commonly performed diagnostic CT examinations are higher and more variable than generally quoted, highlighting the need for greater standardization across institutions.
Journal ArticleDOI
Body-Mass Index and Mortality among 1.46 Million White Adults
Amy Berrington de Gonzalez,Patricia Hartge,James R. Cerhan,Alan J. Flint,Lindsay M. Hannan,Robert J. MacInnis,Robert J. MacInnis,Steven C. Moore,Geoffrey S. Tobias,Hoda Anton-Culver,Laura E. Beane Freeman,W. Lawrence Beeson,Sandra Clipp,Dallas R. English,Aaron R. Folsom,D. Michal Freedman,Graham G. Giles,Niclas Håkansson,Katherine D. Henderson,Judith Hoffman-Bolton,Jane A. Hoppin,Karen L. Koenig,I. Min Lee,Martha S. Linet,Yikyung Park,Gaia Pocobelli,Arthur Schatzkin,Howard D. Sesso,Elisabete Weiderpass,Bradley J. Willcox,Alicja Wolk,Anne Zeleniuch-Jacquotte,Walter C. Willett,Michael J. Thun +33 more
TL;DR: In white adults, overweight and obesity (and possibly underweight) are associated with increased all-cause mortality and the hazard ratios for the men were similar.
Journal ArticleDOI
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
Emanuele Di Angelantonio,Shilpa N Bhupathiraju,David Wormser,Pei Gao,Pei Gao,Stephen Kaptoge,Amy Berrington de Gonzalez,Benjamin J Cairns,Rachel R. Huxley,Chandra L. Jackson,Grace Joshy,Sarah Lewington,JoAnn E. Manson,Neil Murphy,Alpa V. Patel,Jonathan M. Samet,Mark Woodward,Mark Woodward,Mark Woodward,Wei Zheng,Maigen Zhou,Narinder Bansal,Aurelio Barricarte,Brian D. Carter,James R. Cerhan,Rory Collins,George Davey Smith,Xianghua Fang,Oscar H. Franco,Jane Green,Jim Halsey,Janet S. Hildebrand,Keum Ji Jung,Rosemary J. Korda,Dale McLerran,Steven C. Moore,Linda M. O’Keeffe,Ellie Paige,Anna Ramond,Gillian K Reeves,Betsy Rolland,Carlotta Sacerdote,Naveed Sattar,Eleni Sofianopoulou,June Stevens,Michael J. Thun,Hirotsugu Ueshima,Ling Yang,Young Duk Yun,Peter Willeit,Peter Willeit,Emily Banks,Valerie Beral,Zhengming Chen,Susan M. Gapstur,Marc J. Gunter,Patricia Hartge,Sun Ha Jee,Tai Hing Lam,Richard Peto,John D. Potter,Walter C. Willett,Simon G. Thompson,John Danesh,Frank B. Hu +64 more
TL;DR: The associations of both overweight and obesity with higher all-cause mortality were broadly consistent in four continents and supports strategies to combat the entire spectrum of excess adiposity in many populations.
Journal ArticleDOI
Projected cancer risks from computed tomographic scans performed in the United States in 2007.
Amy Berrington de Gonzalez,Mahadevappa Mahesh,Kwang Pyo Kim,Mythreyi Bhargavan,Mythreyi Bhargavan,Rebecca S. Lewis,Fred A. Mettler,Charles E. Land +7 more
TL;DR: These detailed estimates highlight several areas of CT scan use that make large contributions to the total cancer risk, including several scan types and age groups with a high frequency of use or scans involving relatively high doses, in which risk-reduction efforts may be warranted.